-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师总结如下:在第一季度财报发布后,我们将OTIS的12个月目标股价从100美元下调至90美元,市盈率设定为2027年每股收益预期4.58美元的19.6倍(此前预期为4.70美元;2026年每股收益预期从4.25美元上调至4.18美元)。考虑到持续的利润率不利因素何时显现尚不明朗,这一估值较工业机械同行和OTIS五年预期市盈率均有一定程度的折让。由于劳动力和材料成本高于定价成本,第一季度服务利润率令人失望(下降160个基点至23%)。中国市场的疲软态势尚未稳定,但正如之前所述,这部分业务在OTIS的业务组合中所占比例正在缩小,未来影响将较为有限。总体而言,最新季度的情况与上一季度基本相同(中国市场疲软/新设备需求下降),但服务业务(奥的斯整体的核心利润驱动力)的利润率质量面临压力,这令人担忧。尽管公司正在努力提升盈利能力,但我们认为复苏的时间尚不明朗。
Related Articles
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.
Sprintex Raising AU$1.1 Million Via Convertible Notes Issue
Sprintex (ASX:SIX) is raising about AU$1.1 million through the issue of nearly 1.1 million convertible notes at a price of AU$1 each, according to a Monday filing with the Australian bourse.The notes will mature on June 30, 2027, and bear interest at 8% per year, per the filing.Holders of the notes can convert them into Sprintex ordinary shares at any time after June 30 and before their maturity.The company said it plans to use the funds for general working capital purposes, to expand its sales team, and to fulfill customer orders.
Immutep Says Bank of New York Mellon Increases Stake
Immutep (ASX:IMM) received notice that Bank of New York Mellon and its affiliated entities increased their holdings in the company to 21.11% from 20.08%, according to a Monday filing with the Australian bourse.Bank of New York Mellon and its affiliates now owns over 311 million shares in the company, the filing said.